Katayun I. Jaffari, a partner in Ballard Spahr's Business and Finance Department, has been named Secretary of the Board of Directors of the Scleroderma Foundation, Delaware Valley Chapter (SFDV). Ms. Jaffari also serves on the Executive Committee as a result of her appointment to the position of Secretary.

Ms. Jaffari has been a member of the SFDV Board since March 2010. She became deeply committed to raising research dollars and increasing the public's knowledge about scleroderma after her mother was diagnosed with the disease.

The SFDV was founded in 1988 as a chapter of the national Scleroderma Foundation serving eastern Pennsylvania, southern/central New Jersey, and Delaware. Its mission is threefold: to raise funds for research on the cause and treatment of scleroderma, a rare and chronic auto-immune disease that affects nearly 300,000 people in the United States, most of them women; to offer support programs for patients and their families; and to educate the public and medical professionals about the disease.

At Ballard Spahr, Ms. Jaffari handles complex securities transactions for businesses in a variety of industries, particularly those in the biotechnology, energy, and technology sectors. Recognized as a leader in the fields of corporate governance and securities, Ms. Jaffari has advised clients in multibillion-dollar deals and has broad experience in public offerings, stock-for-stock mergers, private placements of common stock, and offerings of convertible notes. Her practice also includes business counseling, capital raising, and mergers and acquisitions. She is licensed to practice law in New Jersey, Pennsylvania, and the District of Columbia.

Related Area